← Back to Search

Aerobic Exercise for Childhood Cognition

N/A
Recruiting
Research Sponsored by Northeastern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participants must have not yet reached, or be in the earliest stages, of puberty, as measured by a modified test of the Tanner Staging System (onset of puberty as determined by Tanner)
Participants must have had no prior diagnosis of cognitive or physical disability, including attention deficit hyperactivity disorder (severe asthma, epilepsy, chronic kidney disease, and dependence upon a wheelchair/walking aid)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up ~1 hr after arriving at lab, after completing the experimental condition
Awards & highlights

Study Summary

This trial will examine the mechanisms linking acute aerobic exercise to improved cognitive control as well as the underlying neuroelectrical activities in children.

Who is the study for?
This trial is for English-speaking children with normal or corrected-to-normal vision, who have not been diagnosed with cognitive or physical disabilities, including severe asthma and epilepsy. They should not be on any psychiatric medications and must be prepubescent as determined by the Tanner Staging System.Check my eligibility
What is being tested?
The study tests how a single session of moderate-intensity aerobic exercise affects brain function and cognition in children compared to seated rest. It uses EEGs to monitor brain activity and assesses whether changes in sympathetic nervous system activity (measured by saliva) explain exercise's effects.See study design
What are the potential side effects?
Since this trial involves non-invasive procedures like exercise, resting, stress tests, and EEG recordings, side effects are minimal but may include typical reactions to physical activity such as fatigue or shortness of breath.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am pre-puberty or in the early stages of puberty.
Select...
I have never been diagnosed with a cognitive or physical disability.
Select...
I am not taking any medication for mental health or ADHD.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~~1 hr after arriving at lab, after completing the experimental condition
This trial's timeline: 3 weeks for screening, Varies for treatment, and ~1 hr after arriving at lab, after completing the experimental condition for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Academic Achievement outcome
Neuroelectric outcome
inhibitory control
+1 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: Aerobic Exercise InterventionExperimental Treatment1 Intervention
Participants will exercise on a motor-driven treadmill at a constant speed during the 23-min period.
Group II: Trier Social Stress Test for ChildrenActive Control1 Intervention
The Trier Social Stress Test for Children consists of a speech task in which children must finish a story and a mental arithmetic task, completed in front of a camera and two neutral observers.
Group III: Seated RestPlacebo Group1 Intervention
Participants will sit in a comfortable chair, placed in the same room as the motor-driven treadmill, for a period of 25-min.

Find a Location

Who is running the clinical trial?

Northeastern UniversityLead Sponsor
88 Previous Clinical Trials
61,070 Total Patients Enrolled
1 Trials studying Exercise
46 Patients Enrolled for Exercise

Media Library

Aerobic Exercise Intervention Clinical Trial Eligibility Overview. Trial Name: NCT03592238 — N/A
Exercise Research Study Groups: Seated Rest, Aerobic Exercise Intervention, Trier Social Stress Test for Children
Exercise Clinical Trial 2023: Aerobic Exercise Intervention Highlights & Side Effects. Trial Name: NCT03592238 — N/A
Aerobic Exercise Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT03592238 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities for individuals to participate in this research trial?

"According to the clinicaltrials.gov, recruitment for this research study is ongoing. It was initially posted on February 10th 2019 and its most recent amendment took place on May 16th 2022."

Answered by AI

How many participants are enrolled in this research project?

"Affirmative. Information located on clinicaltrials.gov indicates that this experiment is currently in search of participants, with updates made as recently as May 16th 2022. A total of 240 people are needed from 1 medical centre for the study to move forward."

Answered by AI

Could I potentially qualify to participate in this trial?

"This trial is recruiting 240 people aged 9 and 10 who have no prior diagnoses of physical or cognitive impairment such as severe asthma, epilepsy, chronic kidney disease, dependence upon a wheelchair/ walking aid. Furthermore, all participants must be free from anti-psychotic medicine; antidepressants; anxiety medication; attention deficit hyperactivity disorder medications. Additionally those taking part must possess normal vision (20/ 20) and not yet reached the earliest stages of puberty according to Tanner Staging System. Lastly parental / guardian consent is mandatory for participation in this study."

Answered by AI

Is the age requirement for this trial restricted to those under 80 years old?

"The entry requirements for this clinical trial require participants to be between 9 and 10 years of age."

Answered by AI
~7 spots leftby Jul 2024